SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021335
Filing Date
2023-05-11
Accepted
2023-05-11 16:40:04
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20230331.htm   iXBRL 10-Q 2697910
2 EX-31.1 vera-ex31_1.htm EX-31 20809
3 EX-31.2 vera-ex31_2.htm EX-31 20782
4 EX-32.1 vera-ex32_1.htm EX-32 12669
5 EX-32.2 vera-ex32_2.htm EX-32 12919
  Complete submission text file 0000950170-23-021335.txt   8982162

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vera-20230331_def.xml EX-101.DEF 271326
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vera-20230331_cal.xml EX-101.CAL 48497
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vera-20230331_lab.xml EX-101.LAB 496216
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vera-20230331_pre.xml EX-101.PRE 369812
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vera-20230331.xsd EX-101.SCH 67050
67 EXTRACTED XBRL INSTANCE DOCUMENT vera-20230331_htm.xml XML 1461535
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 23911733
SIC: 2834 Pharmaceutical Preparations